LoginRegister
    Govt to introduce NEW definition of Medical Devices: ReportGovt to introduce NEW definition of Medical Devices: Report
    Morepen Labs adds blockbuster Rivaroxaban, Vildagliptin, UDCA to API portfolioMorepen Labs adds blockbuster Rivaroxaban, Vildagliptin, UDCA to API portfolio
    FIRST: Sun Pharma unveils dry-eye treatment drug CEQUA in USFIRST: Sun Pharma unveils dry-eye treatment drug CEQUA in US
    Torrent Pharma recalls bottles of Losartan over CGMP deviationsTorrent Pharma recalls bottles of Losartan over CGMP deviations
    JnJ Ebola vaccine to arrive in Congo in November: Health AuthoritiesJnJ Ebola vaccine to arrive in Congo in November: Health Authorities
    CDSCO adds another port for enhancing import of drugsCDSCO adds another port for enhancing import of drugs
    Regulation of all medical devices: DoP, AiMeD, Biotech Consortium to create comprehensive roadmapRegulation of all medical devices: DoP, AiMeD, Biotech Consortium to create comprehensive roadmap
    Novartis gets USFDA nod for Beovu for wet Age-related Macular DegenerationNovartis gets USFDA nod for Beovu for wet Age-related Macular Degeneration
    Boehringer Ingelheim Nintedanib gets USFDA Breakthrough Therapy Designation for chronic ILDsBoehringer Ingelheim Nintedanib gets USFDA Breakthrough Therapy Designation for chronic ILDs
    Pfizer, Akcea enter licensing agreement for investigational antisense therapy AKCEA-ANGPTL3-LRxPfizer, Akcea enter licensing agreement for investigational antisense therapy AKCEA-ANGPTL3-LRx
    Gilead, Galapagos reports efficacy, safety results on rheumatoid arthritis drug FilgotinibGilead, Galapagos reports efficacy, safety results on rheumatoid arthritis drug Filgotinib
    Punjab: Chemist shot for denying habit-forming drug to patientPunjab: Chemist shot for denying habit-forming drug to patient
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X